Cuba: Second phase of trials with Soberana Plus in convalescent COVID-19 patients approved

The study, which will be developed at the Institute of Hematology and Immunology and at the National Center for Sex Education, aims to evaluate the safety, reactogenicity and immunogenicity of the Cuban drug.

La entrada Cuba: Second phase of trials with Soberana Plus in convalescent COVID-19 patients approved se publicó primero en OnCubaNews English.